About

Dr. Saifee Mullamitha is an experienced Consultant in Medical Oncology at The Christie NHS Foundation Trust, providing specialist cancer care since 2007. He completed his postgraduate training in Medical Oncology in the Northwest Deanery (UK) and brings over two decades of experience, with a passionate and empathetic focus on the personalised management of both early and advanced colorectal cancer.

He has a special interest in liver-directed therapy, including Selective Internal Radiotherapy (SIRT) and chemo-saturation of the liver within the context of NHS clinical trials. Dr. Mullamitha is also a member of one of the UK's specialised peritoneal tumour MDTs, involved in the management of appendiceal malignancies and colorectal peritoneal metastasis, which entail cytoreductive surgery, HIPEC, and PIPAC (within NHS clinic trial context).

Actively engaged in clinical research, Dr. Mullamitha has served as the lead principal investigator in several national and international trials, including acting as the UK Chief Investigator in a recently completed immunotherapy trial for patients with advanced colorectal cancer.

Dr. Mullamitha is a Fellow of the Royal College of Physicians (RCP) and has held appointments such as Training Program Director for Northwest Medical Oncology, Junior Doctor Lead, and Chair of the Audit Committee at The Christie Hospital. He has also served as an examiner with the South Manchester University Hospitals (now MFT).

Dr. Mullamitha is committed to using the latest evidence-based treatments and maximising treatment opportunities - including immunotherapy and clinical trials - for patients for optimum survival, whilst also focussing crucially on the quality of life.